Literature DB >> 118835

Cellular immunity in patients with meningococcal disease and in vaccinated subjects.

B M Greenwood, A J Oduloju, M A Ade-Serrano.   

Abstract

Cell-mediated immunity was studied in patients with group A meningococcal meningitis and in normal subjects given group A meningococcal vaccine. Lymphocytes responsiveness to phytohaemagglutinin and to meningococcal antigens was markedly depressed in patients with acute meningococcal infection. This defect was present when lymphocytes were cultured in autologous or foetal calf serum. Patients also showed a transient increase in the degree of inhibition produced by whole group A meningococci in leucocyte migration assays. Meningococci of other groups produced a similar degree of inhibition. Vaccination with group A meningococcal polysaccharide vaccine had no effect on lymphocytes responsiveness to meningococcal antigens or on the inhibitory effect of group A meningococci on leucocyte migration.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 118835      PMCID: PMC1537847     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Anergy in patients with leukocytosis.

Authors:  L I Heiss; D L Palmer
Journal:  Am J Med       Date:  1974-03       Impact factor: 4.965

2.  Demonstration of delayed hypersensitivity to Neisseria meningitidis.

Authors:  J F Pribnow; D J Besemer; J M Hall; N A Vedros
Journal:  Can J Microbiol       Date:  1973-12       Impact factor: 2.419

3.  Effect of viral and bacterial pneumonias on cell-mediated immunity in humans.

Authors:  C A Kauffman; C C Linnemann; G M Schiff; J P Phair
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

4.  Sequential studies of lymphocyte responsiveness and antibody formation in acute bacterial meningitis.

Authors:  V Andersen; N E Hansen; H Karle; I Lind; N Hoiby; B Weeke
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

5.  Transformation of lymphocytes in gonorrhea before and after therapy.

Authors:  V Esquenazi; M M Streitfeld
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

6.  Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.

Authors:  M L Lepow; I Goldschneider; R Gold; M Randolph; E C Gotschlich
Journal:  Pediatrics       Date:  1977-11       Impact factor: 7.124

7.  Cell-mediated immune response in gonococcal infections.

Authors:  F A Wyle; C Rowlett; T Blumenthal
Journal:  Br J Vener Dis       Date:  1977-12

8.  Lymphocyte transformation in repeated gonococcal urethritis.

Authors:  S J Kraus; G H Perkins; R C Geller
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

9.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Cellular immune responses during gonococcal and meningococcal infections.

Authors:  M D Cooper; E J Moticka
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

2.  Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.

Authors:  J Melancon; R A Murgita; I W Devoe
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

3.  Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection.

Authors:  J P Woods; J A Frelinger; G Warrack; J G Cannon
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

4.  Increased CD4(+) T cell co-inhibitory immune receptor CEACAM1 in neonatal sepsis and soluble-CEACAM1 in meningococcal sepsis: a role in sepsis-associated immune suppression?

Authors:  Michiel van der Flier; Dyana B Sharma; Silvia Estevão; Marieke Emonts; Denise Rook; Jan A Hazelzet; Johannes B van Goudoever; Nico G Hartwig
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.